Chromadex Total Liab from 2010 to 2024
| CDXC Stock | USD 7.44 0.19 2.49% |
Total Liabilities | First Reported 2006-12-31 | Previous Quarter 23.3 M | Current Value 22.2 M | Quarterly Volatility 9.5 M |
Check Chromadex Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chromadex Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 863.7 K, Interest Expense of 3.3 K or Selling General Administrative of 16.5 M, as well as many indicators such as Price To Sales Ratio of 1.22, Dividend Yield of 0.0 or PTB Ratio of 3.58. Chromadex financial statements analysis is a perfect complement when working with Chromadex Corp Valuation or Volatility modules.
Chromadex | Total Liab |
Latest Chromadex Corp's Total Liab Growth Pattern
Below is the plot of the Total Liab of Chromadex Corp over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Chromadex Corp's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chromadex Corp's overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
Chromadex Total Liab Regression Statistics
| Arithmetic Mean | 14,296,870 | |
| Geometric Mean | 6,165,961 | |
| Coefficient Of Variation | 67.45 | |
| Mean Deviation | 8,340,175 | |
| Median | 13,474,535 | |
| Standard Deviation | 9,642,913 | |
| Sample Variance | 93T | |
| Range | 27.8M | |
| R-Value | 0.97 | |
| Mean Square Error | 6T | |
| R-Squared | 0.94 | |
| Slope | 2,090,773 | |
| Total Sum of Squares | 1301.8T |
Chromadex Total Liab History
About Chromadex Corp Financial Statements
Chromadex Corp stakeholders use historical fundamental indicators, such as Chromadex Corp's Total Liab, to determine how well the company is positioned to perform in the future. Although Chromadex Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chromadex Corp's assets and liabilities are reflected in the revenues and expenses on Chromadex Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chromadex Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 26.5 M | 27.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:Check out the analysis of Chromadex Corp Correlation against competitors. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.